SARS-CoV-2: What do we know so far?

Acta Physiol (Oxf). 2020 Jun;229(2):e13470. doi: 10.1111/apha.13470. Epub 2020 Apr 11.

Authors

Pratik H Khedkar¹, Andreas Patzak¹

Affiliation

¹ Institut für Vegetative Physiologie, Charité - Universitätsmedizin Berlin, corporate member of the Freie Universität Berlin, Humboldt Universität zu Berlin and the Berlin Institute of Health, Berlin, Germany.

No abstract available

Publication types

Editorial

MeSH terms

Antiviral Agents / chemistry
Antiviral Agents / therapeutic use
Betacoronavirus / growth & development
Betacoronavirus / physiology*
COVID-19
Coronavirus Infections / epidemiology
Coronavirus Infections / therapy
Coronavirus Infections / transmission
Coronavirus Infections / virology*
Humans
Immunity, Herd
Pandemics
Pneumonia, Viral / epidemiology
Pneumonia, Viral / therapy
Pneumonia, Viral / transmission
Pneumonia, Viral / virology*
SARS-CoV-2
Viral Vaccines / immunology

Substances

Antiviral Agents
Viral Vaccines